Insider Transactions in Q2 2023 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-6.58%
|
$360,000
$36.0 P/Share
|
|
Jun 21
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.18%
|
$180,000
$18.41 P/Share
|
|
May 05
2023
|
Matthew L. Posard |
BUY
Grant, award, or other acquisition
|
Direct |
8,065
+6.65%
|
-
|
|
May 05
2023
|
Connie Matsui |
BUY
Grant, award, or other acquisition
|
Direct |
8,065
+4.13%
|
-
|
|
May 05
2023
|
Akiko Moni Miyashita |
BUY
Grant, award, or other acquisition
|
Direct |
8,065
+36.11%
|
-
|
|
May 05
2023
|
Barbara Gayle Duncan |
BUY
Grant, award, or other acquisition
|
Direct |
8,065
+46.57%
|
-
|
|
May 05
2023
|
Jeffrey William Henderson |
BUY
Grant, award, or other acquisition
|
Direct |
8,065
+14.62%
|
-
|
|
May 05
2023
|
Bernadette Connaughton |
BUY
Grant, award, or other acquisition
|
Direct |
8,065
+16.68%
|
-
|
|
May 05
2023
|
James M Daly |
BUY
Grant, award, or other acquisition
|
Direct |
8,065
+16.61%
|
-
|
|
May 05
2023
|
Jean Pierre Bizzari |
BUY
Grant, award, or other acquisition
|
Direct |
8,065
+10.77%
|
-
|
|
Apr 18
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-6.58%
|
$360,000
$36.0 P/Share
|
|
Apr 18
2023
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.18%
|
$180,000
$18.41 P/Share
|